Biotech Stock Nearly 300% Sparks Massive Bet on 2027 Breast Drug
A biotech stock nearly 300% pop grabbed the attention of major investors, culminating in a $68.7 million stake as a b...
Explore Why Low Cost Matters In Index Funds and how even small fee differences compound over time. Practical tips to keep costs down.
26,485 articlesA biotech stock nearly 300% pop grabbed the attention of major investors, culminating in a $68.7 million stake as a b...
A new Fed chair angles for a disciplined inflation fight and a leaner balance sheet, even as markets seek clarity. He...
A steep 2026 selloff has investors weighing Microsoft through a new lens. This guide breaks down the case for microso...
The quantum funding wave from Washington exposes a stark split: IonQ’s rapid revenue growth against IBM’s cash machin...
A new policy debate threatens to tax the income universities earn from licensing taxpayer-funded research, potentiall...
Britain’s crypto rulebook is complete, with a mandatory regime slated for late 2027. This guide explains what changed...
PennantPark Investment’s hefty yield hinges on a reserve that funds part of its payouts and a portfolio heavy in floa...
A DeFi lending protocol disclosed a $403,000 exploit against tokenized stocks used as collateral, exposing weaknesses...
When a senior executive at Maze Therapeutics sells a stake after positive trial data and solid quarterly results, inv...
A senior insider at Septerna sold nearly 12,000 shares in a single move, raising questions for investors. This articl...
Wheaton's Q1 2026 earnings transcript offers clues about margins, cash flow, and future growth in the gold streaming ...
A crypto treasury firm AVAX faced Nasdaq scrutiny but bounced back after a strategic reverse split. This article brea...